Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON33739Not yet recruiting
Randomised, open-label trial in catheter-associated bloodstream infection (CRBSI) comparing Ethanol lock therapy with Placebo lock therapy (2 arms). Primary endpoint: Treatment failure. Planned start Sep 2008; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON33739.